Abstract
Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Current Molecular Medicine
Title:The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation
Volume: 17 Issue: 1
Author(s): L. Liu, Y. Wei and X. Wei*
Affiliation:
- Laboratory for Aging Research, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041,China
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Abstract: Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Export Options
About this article
Cite this article as:
Liu L., Wei Y. and Wei X.*, The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation, Current Molecular Medicine 2017; 17 (1) . https://dx.doi.org/10.2174/1566524017666170220102732
DOI https://dx.doi.org/10.2174/1566524017666170220102732 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Complications of the Type 2 Diabetes Mellitus
Current Cardiology Reviews Editorial: Pain in Dementia: A Distressing Combination of Several Factors
Current Alzheimer Research Development of Pyrazole Compounds as Antidiabetic Agent: A Review
Letters in Drug Design & Discovery An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Simultaneous Determination of Simvastatin with Caffeine in Bulk Drug, Formulation and their Monitoring in Mice Plasma Through HPLC-PDA Technique
Current Analytical Chemistry mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Anti-Inflammatory Agents in Ageing and Age-Associated Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hymenoptera Venom Proteins and Peptides for Diagnosis and Treatment of Venom Allergic Patients
Inflammation & Allergy - Drug Targets (Discontinued) FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment
Current HIV Research Targeting Phosphatidylserine in Anti-Cancer Therapy
Current Pharmaceutical Design Vitamin D Intake and Obesity in Occupational Asthma Patients and the Need for Supplementation
Endocrine, Metabolic & Immune Disorders - Drug Targets Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety Abstracts from Speakers
Cardiovascular & Hematological Disorders-Drug Targets Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years
Current Vascular Pharmacology Recent Progress in Pharmacological Research of Antioxidants in Pathological Conditions: Cardiovascular Health
Recent Patents on Anti-Infective Drug Discovery Drug Delivery Systems for Ophthalmic Administration of Antiinflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry